C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk

le Eklund, C M, Tammela, T L J, Schleutker, J, Hurme, M
Foilsithe 2009

MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families

le Fischer, Daniel, Wahlfors, Tiina, Mattila, Henna, Oja, Hannu, Tammela, Teuvo L. J., Schleutker, Johanna
Foilsithe in PLoS One (2015)

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial

le Murtola, T J, Tammela, T L J, Määttänen, L, Ala-opas, M, Stenman, U H, Auvinen, A
Foilsithe 2009

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial

le Veitonmäki, T, Murtola, T J, Määttänen, L, Taari, K, Stenman, U-H, Tammela, T L J, Auvinen, A
Foilsithe 2014

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer

le Kinnunen, Pete T. T., Murtola, Teemu J., Talala, Kirsi, Taari, Kimmo, Tammela, Teuvo L. J., Auvinen, Anssi
Foilsithe in BMC Cancer (2017)

Antihypertensive drug use and prostate cancer-specific mortality in Finnish men

le Siltari, Aino, Murtola, Teemu J., Talala, Kirsi, Taari, Kimmo, Tammela, Teuvo L. J., Auvinen, Anssi
Foilsithe in PLoS One (2020)

Prostate cancer risk prediction using a polygenic risk score

le Sipeky, Csilla, Talala, Kirsi M., Tammela, Teuvo L. J., Taari, Kimmo, Auvinen, Anssi, Schleutker, Johanna
Foilsithe in Sci Rep (2020)

Prognostic utility of human complement factor H related protein test (the BTA stat® Test)

le Raitanen, M-P, Kaasinen, E, Rintala, E, Hansson, E, Nieminen, P, Aine, R, Tammela, T L J
Foilsithe 2001

Outcomes of prostate cancer screening among men using antidiabetic medication

le Vettenranta, A., Murtola, T. J., Talala, K., Taari, K., Stenman, U.-H., Tammela, T. L. J., Auvinen, A.
Foilsithe in Sci Rep (2021)

Expression and ERG regulation of PIM kinases in prostate cancer

le Eerola, Sini K., Kohvakka, Annika, Tammela, Teuvo L. J., Koskinen, Päivi J., Latonen, Leena, Visakorpi, Tapio
Foilsithe in Cancer Med (2021)

Is the Prevalence of Overactive Bladder Overestimated? A Population-Based Study in Finland

le Tikkinen, Kari A.O., Tammela, Teuvo L.J., Rissanen, Aila M., Valpas, Antti, Huhtala, Heini, Auvinen, Anssi
Foilsithe 2007

Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma

le Kallio, J P, Hirvikoski, P, Helin, H, Kellokumpu-Lehtinen, P, Luukkaala, T, Tammela, T L J, Martikainen, P M
Foilsithe 2003

The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth

le Murtola, Teemu J., Syvälä, Heimo, Pennanen, Pasi, Bläuer, Merja, Solakivi, Tiina, Ylikomi, Timo, Tammela, Teuvo L. J.
Foilsithe 2012

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

le Mononen, N, Ikonen, T, Syrjäkoski, K, Matikainen, M, Schleutker, J, Tammela, T L J, Koivisto, P A, Kallioniemi, O P
Foilsithe 2001

CHEK2 variants associate with hereditary prostate cancer

le Seppälä, E H, Ikonen, T, Mononen, N, Autio, V, Rökman, A, Matikainen, M P, Tammela, T L J, Schleutker, J
Foilsithe 2003

Fine-mapping the 2q37 and 17q11.2-q22 Loci for Novel Genes and Sequence Variants Associated with a Genetic Predisposition to Prostate Cancer

le Laitinen, Virpi H., Rantapero, Tommi, Fischer, Daniel, Vuorinen, Elisa M., Tammela, Teuvo L.J., Wahlfors, Tiina, Schleutker, Johanna
Foilsithe in Int J Cancer (2014)

Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men

le Kaapu, Kalle J., Rantaniemi, Lauri, Talala, Kirsi, Taari, Kimmo, Tammela, Teuvo L. J., Auvinen, Anssi, Murtola, Teemu J.
Foilsithe in Sci Rep (2018)

Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer

le Savinainen, K J, Linja, M J, Saramäki, O R, Tammela, T L J, Chang, G T G, Brinkmann, A O, Visakorpi, T
Foilsithe 2004

False-positive screening results in the Finnish prostate cancer screening trial

le Kilpeläinen, T P, Tammela, T L J, Määttänen, L, Kujala, P, Stenman, U-H, Ala-Opas, M, Murtola, T J, Auvinen, A
Foilsithe 2010

Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data

le Booth, Neill, Rissanen, Pekka, Tammela, Teuvo L. J., Kujala, Paula, Stenman, Ulf-Håkan, Taari, Kimmo, Talala, Kirsi, Auvinen, Anssi
Foilsithe in PLoS One (2019)